当前位置: 首页 > 期刊 > 《中国医学创新》 > 2024年第23期
编号:2222633
HCC根治性切除术后早期复发的危险因素及预测因子研究进展
http://www.100md.com 2024年9月22日 中国医学创新 2024年第23期
     【摘要】 肝细胞癌(HCC)作为恶性程度较高的恶性肿瘤。具有发展快、侵袭性高、预后差等特点。对于早期的HCC患者来说根治性切除术目前还是首选治疗手段。但根治性切除术后的早期复发率较高影响预后。所以能提前了解术后早期复发的相关危险因素及预测因子,并对其进行及时的监测和提前干预显得十分重要。本文旨在概述和分析近年来国内外相关领域的研究进展与趋势,以期对该领域未来的发展方向提供参考和启示。

    【关键词】 肝细胞癌 早期复发 危险因素 预测因子

    Research Progress on Risk Factors and Predictors of Early Recurrence of HCC after Radical Resection/GAO Chaobin, YU Cong, MIAO Huilai. //Medical Innovation of China, 2024, 21(23): -163

    [Abstract] Hepatocellular carcinoma (HCC) is a malignant tumor with a high degree of malignancy. It has the characteristics of rapid development, high invasiveness and poor prognosis. Radical resection is still the first treatment for early stage HCC patients. However, the early recurrence rate after radical resection affects the prognosis. Therefore, it is very important to understand the risk factors and predictors of early postoperative recurrence in advance, and conduct timely monitoring and early intervention. This paper aims to summarize and analyze the research progress and trend in related fields at home and abroad in recent years, in order to provide reference and inspiration for the future development direction of this field. ......

您现在查看是摘要页,全文长 21322 字符